Eltrombopag: Noninferior to Intravenous Immunoglobulin in Immune Thrombocytopenia?
Eltrombopag may be an effective alternative to intravenous immunoglobulin for the perioperative treatment of immune thrombocytopenia.
Idiopathic Thrombocytopenic Purpura
4R+3Dex Regimen May Lead to Durable Complete Response in Pediatric Chronic ITP
Young patients with chronic ITP may experience relapse within 5 years of completing therapy. In this study, investigators sought to determine if the 4R+3Dex regimen for chronic ITP would improve response rates in pediatric patients with the disease.
Rituximab vs Splenectomy: Response Similar in Immune Thrombocytopenic Purpura
Results of a retrospective single-center study showed that response to rituximab vs splenectomy as second-line therapy for steroid-refractory ITP was not significantly different between the 2 treatments.
Rare Case of Langerhans Cell Histiocytosis With Prior ITP Highlights Diagnostic Challenge for Clinicians
A rare case of Langerhans cell histiocytosis (LCH) in a patient with idiopathic thrombocytopenic purpura (ITP) highlights the difficulty in diagnosing LCH.
Immune Thrombocytopenia (Fact Sheet)
This fact sheet examines immune thrombocytopenia (ITP), including patient outlook, treatment, and ITP in pregnancy.
IL-11 Plus Glucocorticoids Safe, Effective for ITP in Adults
Recent study results demonstrate that recombinant IL-11 with glucocorticoids is a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP) in adults.
Eradication of Infection Improves Outcomes for H Pylori+ patients with ITP
Approximately 40% of ITP cases are caused by gram-negative H pylori infection; therefore, researchers sought to determine the effectiveness of infection eradication on platelet count in these patients.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...